UNSPSC 51373463: Guaifenesin/hydrocodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373463 Guaifenesin/hydrocodone is a Commodity code covering controlled pharmaceutical products that state and local governments procure for health services within correctional and public-health settings. Recent solicitations show state and local buyers are acquiring parenteral nutrition solutions, intravenous products, naloxone, and drug-deactivation systems — goods that go well beyond the single-drug name in the code's title and reflect broader pharmaceutical-procurement categories used by issuing bodies in practice. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body mix: state corrections departments and county health agencies are the primary users, with procurement structured around multi-year contracts and quarterly or on-demand delivery cycles. Correctional healthcare is the dominant use case, where parenteral products must meet tight delivery windows (24 hours for specialized nutrition, 8 hours for standard parenteral stock) to support medically necessary care for incarcerated individuals.

Activity under this code concentrates in Washington state and Florida. The Washington State Department of Corrections issued RFQQK13020 for parenteral products, services, and equipment with a response deadline of October 7, 2026, soliciting bids to serve eight correctional facilities across three regions; the agency expects to select multiple contractors (up to three per region) under a term running November 26, 2026 through June 30, 2030. Seminole County, Florida issued IFB60459723LAS for 1,900 units of naloxone and 800 drug-deactivation systems annually with a response deadline of July 26, 2023 (note: this opportunity is date-stale relative to the posting activity block and may reflect historical record). Both solicitations emphasize compliance with state business-licensing and background-clearance requirements, insurance minimums, and drug-free workplace certification. The Washington solicitation explicitly sets aspirational small-business, minority-owned business, women-owned business, and veteran-owned business goals (collectively 46%), signaling receptiveness to certified diverse vendors in this space.